🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 24-week study investigating the safety and efficacy of several do...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-28
Trial ID
NCT00111800
Treatments Being Tested
The purpose of this study is to determine predictors of response to pioglit...
Status
Completed
Location
University of Maryland School of Medicine
Start Date
2009-03
Trial ID
NCT01135394
Treatments Being Tested
Determine the doses and schedule appropriate for phase 2 study of sorafenib...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-01-29
Trial ID
NCT02349867
Gender-identity differences are becoming increasingly diagnosed in the US a...
Status
Withdrawn
Location
Yale School of Medicine
Start Date
2022-09-30
Trial ID
NCT04922424
Treatments Being Tested
The aim of this study is comparing the effects of non-pharmacological inter...
Status
Completed
Location
Bambino Gesù Hospital and Research Institute
Start Date
2021-02-08
Trial ID
NCT04964427
Treatments Being Tested
To determine the effect of denosumab treatment compared with placebo over 1...
Status
Completed
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT00043186
Treatments Being Tested
Patients with chronic renal insufficiency usually develop secondary osteopo...
Status
Unknown
Location
Anhui Province Hospital of TCM
Start Date
2012-10
Trial ID
NCT02147782
This is a multicenter observational cohort study with both retrospective an...
Status
Completed
Location
Research Site
Start Date
2016-12-06
Trial ID
NCT02993120
Metabolic defects contributing to the development of type 2 diabetes (T2D) ...
Status
Completed
Location
Diabetes Research Institute
Start Date
2008-04
Trial ID
NCT01156597
Treatments Being Tested
This is a Phase 1, double-blind (Sponsor-open), placebo-controlled, randomi...
Status
Completed
Location
High Point Clinical Trials Center
Start Date
2022-07-07
Trial ID
NCT05462132
Treatments Being Tested